IDEXX Laboratories Inc

NASDAQ:IDXXUnited States

May 14, 2024

Show headlines and story abstract

• IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day, from 2:00PM ET on Tuesday May 14, 2024 by Business Wire

  2:00PM ET on Tuesday May 14, 2024 by Business Wire
  Companies Mentioned: IDXX

  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 10:55 am - 11:25 am (EDT).

• IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day, from 2:00PM ET on Tuesday May 14, 2024 by Dow Jones

  2:00PM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: IDXX
  WESTBROOK, Maine--(BUSINESS WIRE)--May 14, 2024--
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 10:55 am -- 11:25 am (EDT).
  

• DJ IDEXX Labs Is Maintained at Overweight by Morgan Stanley, from 1:07PM ET on Tuesday May 14, 2024 by Dow Jones

  1:07PM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: IDXX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IDXX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 14, 2024 13:07 ET (17:07 GMT)
  

• Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620, from 8:27AM ET on Tuesday May 14, 2024 by MT Newswires

  8:27AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: IDXX
  08:27 AM EDT, 05/14/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $641, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research ...